Substandard medicines in Nepal: a crisis of access, equity, and a call for action.
作者信息
Ghimire Animesh
机构信息
Sustainable Prosperity Initiative Nepal, Kathmandu, Nepal.
Faculty of Medicine, Nursing and Health Science, Monash University, Melbourne, VIC, Australia.
出版信息
Front Public Health. 2025 Aug 29;13:1584872. doi: 10.3389/fpubh.2025.1584872. eCollection 2025.
Abstract
摘要
相似文献
1
Substandard medicines in Nepal: a crisis of access, equity, and a call for action.
Front Public Health. 2025 Aug 29;13:1584872. doi: 10.3389/fpubh.2025.1584872. eCollection 2025.
2
Medicine quality assessment in Nepal using semi randomised sampling and evaluation of a small scale dissolution test and portable Raman spectrometers.
Sci Rep. 2025 Aug 21;15(1):30746. doi: 10.1038/s41598-025-16340-7.
3
Modelling the economic impact of substandard uterotonics on postpartum haemorrhage in Nigeria: safeguarding medicine quality can reduce costs and contribute towards universal health coverage.
BMJ Public Health. 2025 Apr 5;3(1):e000624. doi: 10.1136/bmjph-2023-000624. eCollection 2025 Jan.
4
Impact of reduced institutional delivery coverage on neonatal survival during the peak of coronavirus disease 2019 pandemic in Nepal: Estimates using Lives Saved Tool model.
Womens Health (Lond). 2025 Jan-Dec;21:17455057251347717. doi: 10.1177/17455057251347717. Epub 2025 Jul 19.
5
The economic and health impact of substandard uterotonic use for prevention of postpartum hemorrhage in three Sub-Saharan African countries: a comparative analysis.
Health Res Policy Syst. 2025 Jul 1;23(1):86. doi: 10.1186/s12961-025-01322-y.
6
Inequities in effective coverage of family planning services in low- and middle-income countries: linking household and facility surveys.
J Glob Health. 2025 Sep 12;15:04211. doi: 10.7189/jogh.15.04211.
7
Demonstration of an End-To-End Workflow Using Atmospheric Solids Analysis Probe-Mass Spectrometry (ASAP-MS) With Real-Time Sample Recognition Software for the Identification of Falsified and Substandard Pharmaceutical Tablets.
Drug Test Anal. 2025 Jul;17(7):1096-1106. doi: 10.1002/dta.3816. Epub 2024 Oct 12.
8
The Political Economy of the World Health Organization Model Lists of Essential Medicines.
Milbank Q. 2025 Mar;103(1):52-99. doi: 10.1111/1468-0009.70001. Epub 2025 Feb 27.
9
Substandard anticancer medications in clinical care settings and private pharmacies in sub-Saharan Africa: a systematic pharmaceutical investigation.
Lancet Glob Health. 2025 Jul;13(7):e1250-e1257. doi: 10.1016/S2214-109X(25)00138-X.
10
Exploring Service Users' Experiences of a Community-Based Intervention to Improve Follow-Up at Bharatpur Eye Hospital in Nepal: Qualitative Study.
JMIR Pediatr Parent. 2025 Jun 25;8:e65023. doi: 10.2196/65023.
本文引用的文献
1
Supervision, performance assessment, and recognition strategy (SPARS) - a multipronged strategy to strengthen medicines management in Nepal: pilot study methods and baseline results.
J Pharm Policy Pract. 2025 Jan 20;18(1):2449043. doi: 10.1080/20523211.2024.2449043. eCollection 2025.
2
Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance.
Eur J Pharm Sci. 2024 Dec 1;203:106938. doi: 10.1016/j.ejps.2024.106938. Epub 2024 Oct 16.
3
Global perspective of the risks of falsified and counterfeit medicines: A critical review of the literature.
Travel Med Infect Dis. 2024 Sep-Oct;61:102758. doi: 10.1016/j.tmaid.2024.102758. Epub 2024 Aug 30.
4
Inventory Control Mechanism of the Pharmacy Store of a Recently Established National Institute in Eastern India: A Cross-Sectional, Investigative Analysis.
Cureus. 2023 Nov 29;15(11):e49632. doi: 10.7759/cureus.49632. eCollection 2023 Nov.
5
Assessment of quality of essential medicines in public health care facilities of Nepal: Findings of nationwide study.
PLOS Glob Public Health. 2023 May 25;3(5):e0001841. doi: 10.1371/journal.pgph.0001841. eCollection 2023.
6
Counterfeit Healthcare Products: Nepal at a Vulnerable Position.
JNMA J Nepal Med Assoc. 2022 Dec 1;60(256):1070-1072. doi: 10.31729/jnma.7684.
7
Pharmacovigilance: reporting requirements throughout a product's lifecycle.
Ther Adv Drug Saf. 2022 Sep 27;13:20420986221125006. doi: 10.1177/20420986221125006. eCollection 2022.
8
Falsified and substandard medicines trafficking: A wakeup call for the African continent.
Public Health Pract (Oxf). 2022 Feb 26;3:100240. doi: 10.1016/j.puhip.2022.100240. eCollection 2022 Jun.
9
Review of drug recalls and quality of pharmaceutical products in Nepal.
BMJ Open. 2022 Jul 4;12(7):e053479. doi: 10.1136/bmjopen-2021-053479.
10
Blockchain technology in the pharmaceutical industry: a systematic review.
PeerJ Comput Sci. 2022 Mar 11;8:e840. doi: 10.7717/peerj-cs.840. eCollection 2022.
Zotero 插件